Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant

Journal of Heart and Lung Transplantation

Volumn 32, Issue 3, 2013, Pages 313-319

  Monforte, Victor ^a,b   López Sánchez, Almudena ^c   Zurbano, Felipe ^d   Ussetti, Piedad ^e   Solé, Amparo ^f   Casals, Cristina ^c   Cifrian, José ^d   De Pablos, Alicia ^g   Bravo, Carles ^a,b   Román, Antonio ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

antifungal prophylaxis; Aspergillosis; Aspergillus; fungal infection; inhaled liposomal amphotericin; lung transplantation; pulmonary surfactant

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AZATHIOPRINE; CHOLESTEROL; CORTICOSTEROID; CYCLOSPORIN; EVEROLIMUS; LIPID; LUNG SURFACTANT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHOLIPID; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; ASPERGILLOSIS; CLINICAL ARTICLE; DRUG ADMINISTRATION ROUTE; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; LIPID BLOOD LEVEL; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY;

ADMINISTRATION, INHALATION; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CHOLESTEROL; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PHOSPHOLIPIDS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PULMONARY SURFACTANTS; TIME FACTORS;

EID: 84873999251     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.11.013     Document Type: Article

References (41)

1. C.F. Neoh, G.I. Snell, and T. Kotsimbos Antifungal prophylaxis in lung transplantation - a world-wide survey Am J Transplant 11 2011 361 366
2. S. Husain, D. Zaldonis, and S. Kusne Variation in antifungal prophylaxis strategies in lung transplantation Transpl Infect Dis 8 2006 213 218
3. J.S. Dummer, N. Lazariashvilli, and J. Barnes A survey of anti-fungal management in lung transplantation J Heart Lung Transplant 23 2004 1376 1381
4. S. Husain, B. Capitano, and T. Corcoran Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients Transplantation 90 2010 1215 1219
5. J.M. Borro, A. Sole, and M. de la Torre Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation Transplant Proc 40 2008 3090 3093
6. T.E. Corcoran, R. Venkataramanan, and K.M. Mihelc Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients Am J Transplant 6 2006 2765 2773
7. R.H. Drew, A.E. Dodds, and D.K. Benjamin Jr Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients Transplantation 77 2004 232 237
8. V. Monforte, A. Roman, and J. Gavalda Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients Transplantation 75 2003 1571 1574
9. V. Monforte, A. Roman, and J. Gavalda Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors J Heart Lung Transplant 20 2001 1274 1281
10. S.M. Palmer, R.H. Drew, and J.D. Whitehouse Safety of aerosolized amphotericin B lipid complex in lung transplant recipients Transplantation 72 2001 545 548
11. H. Reichenspurner, P. Gamberg, and M. Nitschke Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis Transplant Proc 26 1997 627 628
12. C.M. Lowry, F.M. Marty, and S.O. Vargas Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study Transpl Infect Dis 9 2007 121 125
13. V. Monforte, P. Ussetti, and J. Gavalda Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation J Heart Lung Transplant 29 2010 523 530
14. V. Monforte, P. Ussetti, and R. Lopez Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety J Heart Lung Transplant 28 2009 170 175
15. B.C. Cahill, J.R. Hibbs, and K. Savik Aspergillus airway colonization and invasive disease after lung transplantation Chest 112 1997 1160 1164
16. E. Ruffini, S. Baldi, and M. Rapellino Fungal infections in lung transplantation. Incidence, risk factors and prognostic significance Sarcoidosis Vasc Diffuse Lung Dis 18 2001 181 190
17. V. Yeldandi, F. Laghi, and M.A. McCabe Aspergillus and lung transplantation J Heart Lung Transplant 14 1995 883 890
18. R.N. Husni, S.M. Gordon, and D.L. Longworth Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients Clin Infect Dis 26 1998 753 755
19. R. Guillemain, V. Lavarde, and C. Amrein Invasive aspergillosis after transplantation Transplant Proc 27 1995 1307 1309
20. A. Minari, R. Husni, and R.K. Avery The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants Transpl Infect Dis 4 2002 195 200
21. B.C. Trapnell, J.A. Whitsett, and K. Nakata Pulmonary alveolar proteinosis N Engl J Med 349 2003 2527 2539
22. R.A. Veldhuizen, J. Lee, and D. Sandler Alterations in pulmonary surfactant composition and activity after experimental lung transplantation Am Rev Respir Dis 148 1993 208 215
23. C. Casals, A. Varela, and M.L. Ruano Increase of C-reactive protein and decrease of surfactant protein a in surfactant after lung transplantation Am J Respir Crit Care Med 157 1998 43 49
24. J.M. Hohlfeld, E. Tiryaki, and H. Hamm Pulmonary surfactant activity is impaired in lung transplant recipients Am J Respir Crit Care Med 158 1998 706 712
25. F.D. Kermeen, K.D. McNeil, and J.F. Fraser Resolution of severe ischemia-reperfusion injury post-lung transplantation after administration of endobronchial surfactant J Heart Lung Transplant 26 2007 850 856
26. M. Struber, S. Fischer, and J. Niedermeyer Effects of exogenous surfactant instillation in clinical lung transplantation: a prospective, randomized trial J Thorac Cardiovasc Surg 133 2007 1620 1625
27. A. Amital, D. Shitrit, and Y. Raviv The use of surfactant in lung transplantation Transplantation 86 2008 1554 1559
28. A. Amital, D. Shitrit, and Y. Raviv Surfactant as salvage therapy in life threatening primary graft dysfunction in lung transplantation Eur J Cardiothorac Surg 35 2009 299 303
29. B.P. van Putte, P.M. Cobelens, and K.N. van der Exogenous surfactant attenuation of ischemia-reperfusion injury in the lung through alteration of inflammatory and apoptotic factors J Thorac Cardiovasc Surg 137 2009 824 828
30. A. Saenz, L. Alvarez, and M. Santos Beneficial effects of synthetic KL surfactant in experimental lung transplantation Eur Respir J 37 2011 925 932
31. Spanish Agency of Medicines and Medical devices. Liposomal amphotericin B. Data sheet. 2009. (Agencia española de medicamentos y productos sanitarios. Anfotericina B liposomal. Ficha Tecnica. 2009).
32. A.A. Gal, J.A. Bryan, and K.R. Kanter Cytopathology of pulmonary alveolar proteinosis complicating lung transplantation J Heart Lung Transplant 23 2004 135 138
33. C.A. Kelly, C.J. Kotre, and C. Ward Anatomical distribution of bronchoalveolar lavage fluid as assessed by digital subtraction radiography Thorax 42 1987 624 628
34. E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can J Biochem Physiol 37 1959 911 917
35. G. Rouser, A.N. Siakotos, and S. Fleischer Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots Lipids 1 1966 85 86
36. R.A. Veldhuizen, L.A. McCaig, and T. Akino Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome Am J Respir Crit Care Med 152 1995 1867 1871
37. C. O'Callaghan, and P.W. Barry The science of nebulised drug delivery Thorax 52 Suppl 2 1997 S31 S44
38. M. Griese, A. Schams, and K.P. Lohmeier Amphotericin B. and pulmonary surfactant Eur J Med Res 3 1998 383 386
39. E.J. Ruijgrok, A.G. Vulto, and E.W. Van Etten Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats J Antimicrob Chemother 48 2001 89 95
40. F. D'Ovidio, M. Mura, and R. Ridsdale The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D Am J Transplant 6 2006 1930 1938
41. F. Valino, C. Casals, and R. Guerrero Inhaled nitric oxide affects endogenous surfactant in experimental lung transplantation Transplantation 77 2004 812 818